Ticker League

Cash on Hand for Bio-Techne (TECH)

As of · Reported

Metric

Latest period

$209.82M

YoY change

+6.1%

5Y CAGR

-9.8%

Peak year (2014)

$363.35M

Cash on Hand history chart for Bio-Techne (TECH) from 1989 to 2025

Latest: $162.19M

Cash on Hand growth chart for Bio-Techne (TECH) from 1989 to 2025

Latest: +6.1%

Cash on Hand history table for Bio-Techne (TECH) from 1989 to 2025

  • 2025$162.19M+6.1%
  • 2024$152.86M-25.2%
  • 2023$204.31M-17.3%
  • 2022$247.03M+6.7%
  • 2021$231.55M-14.5%
  • 2020$270.89M+63.2%
  • 2019$166.03M-8.6%
  • 2018$181.75M+15.2%
  • 2017$157.71M+64.6%
  • 2016$95.83M-13.6%
  • 2015$110.92M-69.5%
  • 2014$363.35M+9.1%
  • 2013$332.94M+23.8%
  • 2012$268.99M+91.0%
  • 2011$140.81M+1.4%
  • 2010$138.81M-31.6%
  • 2009$202.89M-1.7%
  • 2008$206.34M+25.2%
  • 2007$164.77M+51.4%
  • 2006$108.85M+12.1%
  • 2005$97.13M-45.0%
  • 2004$176.59M+50.3%
  • 2003$117.50M+21.1%
  • 2002$97.06M-0.0%
  • 2001$97.07M+62.3%
  • 2000$59.82M+105.6%
  • 1999$29.10M+6.2%
  • 1998$27.40M+218.6%
  • 1997$8.60M+16.2%
  • 1996$7.40M+39.6%
  • 1995$5.30M-10.2%
  • 1994$5.90M+47.5%
  • 1993$4.00M-11.1%
  • 1992$4.50M+125.0%
  • 1991$2.00M+53.8%
  • 1990$1.30M+30.0%
  • 1989$1.00M—

Cash on Hand values are taken from Bio-Techne's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Bio-Techne (TECH)

According to Bio-Techne's latest reported financial statements, the company's latest reported cash and short-term investments is $209.82M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Bio-Techne (TECH) reported cash and short-term investments of $162.19M – grew 6.1% year-over-year.

Across 2020–2025 (5 years), Bio-Techne cash and short-term investments produced a CAGR of -9.8% – with a net decline across the window.

Between 2014 and 2025, Bio-Techne cash and short-term investments plunged 55.4%, falling from $363.35M to $162.19M.

The highest annual cash and short-term investments of $363.35M was reported in 2014. The lowest in the available history was $1.00M in 1989.

Bio-Techne Cash on Hand by Year

Bio-Techne Cash on Hand 2025: $162.19M

Bio-Techne posted cash and short-term investments of $162.19M in 2025, grew 6.1% from 2024.

Bio-Techne Cash on Hand 2024: $152.86M

In 2024, Bio-Techne reported cash and short-term investments of $152.86M, declined 25.2% below 2023.

Bio-Techne Cash on Hand 2023: $204.31M

Bio-Techne cash and short-term investments in 2023 was $204.31M, declined 17.3% below 2022.

Bio-Techne Cash on Hand 2022: $247.03M

2022's cash and short-term investments for Bio-Techne came in at $247.03M, grew 6.7% from 2021.

Bio-Techne Cash on Hand 2021: $231.55M

Bio-Techne cash and short-term investments in 2021 was $231.55M.

See more financial history for Bio-Techne (TECH).

Sector peers by Cash on Hand

Healthcare peers of Bio-Techne (TECH), ranked by their latest cash and short-term investments

Frequently asked questions

Bio-Techne (TECH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation